20 articles
New research reveals how hormone FGF21 activates brain circuits to boost metabolism and reverse obesity, offering alternative to GLP-1 drugs.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
A clinical trial found testosterone gel plus exercise prevented visceral fat increases in women over 65 recovering from hip fractures.
A small Brazilian trial found 43% of women taking 2,000 IU vitamin D daily achieved complete cancer remission vs 24% on placebo.
A novel ฮฒ2 agonist pill boosts fat burning via skeletal muscle, preserving muscle mass while improving blood sugar in early trials.
Reducing protein to recommended levels may double the longevity hormone FGF21, improving fat loss and insulin sensitivity within weeks.
Biotin supplements taken by cancer patients for hair loss can distort key blood markers, potentially masking cancer recurrence or delaying treatment.
FGF21 extends lifespan in animals by 30-40%. Here's what exercise and diet research reveals about boosting it naturally.
Clinical trials test onion claims on testosterone, bone density, allergies, and cancer โ results are more nuanced than headlines suggest.
A protein thought only to burn fat secretly protects fat cell health from inside the nucleus, reshaping obesity and metabolic disease research.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.
A key fat metabolism protein works inside cell nuclei to keep fat tissue healthy โ its absence causes fat loss, not gain.
A UC San Diego trial shows ION224 blocks liver fat production, cutting inflammation and scarring in 60% of MASH patients.
Women deficient in vitamin D needed far more opioids after mastectomy, suggesting a simple supplement could ease surgical recovery.
University of Sydney researchers found that cutting fat or animal protein for just four weeks lowered biological age markers in older adults.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
A new rat study finds fish oil calms inflammation and improves blood sugar control in non-obese type 2 diabetes โ a largely overlooked patient group.
Japanese scientists engineered hybrid vitamin K molecules that are 3x more potent at regrowing neurons, potentially transforming Alzheimer's treatment.
